Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
LaunchProscia has launched AI biomarker detection for skin tissue as part of its Concentriq software platform, enhancing pathology capabilities.
Oct 15, 2025
PhiladelphiaInformation TechnologySoftware
Product Description
Proscia® announced the addition of AI biomarker detection for skin tissue to its Concentriq® software platform, aimed at improving the efficiency and precision of dermatopathology workflows.
Company Information
Company
Proscia
Location
1700 MARKET STREET
Philadelphia, Pennsylvania, United States
About
Proscia is a software company accelerating pathology’s transition to a digital, data-driven discipline and enabling AI to advance precision medicine. Its Concentriq enterprise pathology platform, precision medicine AI portfolio, and real-world data fuel the development and use of novel therapies and diagnostics to drive the fight against humanity’s most challenging diseases, like cancer. 16 of the top 20 pharmaceutical companies and a global network of diagnostic laboratories rely on Proscia’s solutions each day. The company has FDA 510(k) clearance and CE-IVDR certification for its diagnostic software.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Proscia ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.